Idasanutlin
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Idasanutlin, covering 2018-05-17 to 2024-12-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors [Phase 1, Phase 2]